Business Context and Reporting Period
Company: The Ensign Group, Inc. (ENSG)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: Ensign is a holding company operating independent subsidiaries that provide post-acute care services, including skilled nursing, senior living, and rehabilitation therapy. As of September 30, 2025, the company operated 361 facilities across 17 states with approximately 37,100 skilled nursing beds and 3,400 senior living units. The company utilizes a captive REIT, Standard Bearer Healthcare REIT, Inc., to own and manage its real estate portfolio.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Total Revenue | $1,296,405 | $1,081,776 | $3,697,215 | $3,128,233 |
| Net Income (Attributable to Ensign) | $83,844 | $78,444 | $248,517 | $218,286 |
| Diluted EPS | $1.42 | $1.34 | $4.23 | $3.76 |
| Operating Cash Flow (9M) | $380,950 (2025) vs $246,730 (2024) | |||
| Cash and Equivalents (End of Period) | $443,668 | |||
| Total Debt (Long-term + Current) | $142,748 | |||
| Operating Lease Liabilities | $2,013,763 |
Margins (9M 2025 vs 9M 2024):
- Net Income Margin: 6.7% (2025) vs 7.0% (2024)
- Operating Income Margin: 8.2% (2025) vs 8.3% (2024)
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 19.8% in Q3 2025 and 18.2% for the nine months ended September 30, 2025, compared to the prior year periods. This growth was driven by acquisitions (34 new operations added in the first nine months of 2025) and improved occupancy rates.
- Occupancy: Consolidated skilled nursing occupancy increased to 82.3% in Q3 2025 (up 1.4% from Q3 2024) and 81.8% for the nine-month period (up 1.4% from the prior year). Same-facility occupancy rose 2.1% in Q3.
- Acquisitions: The company spent $240.3 million on acquisitions during the first nine months of 2025, compared to $83.4 million in the same period in 2024. This included 28 stand-alone skilled nursing operations, five senior living operations, and one campus operation.
- Capital Expenditures: Cash used for property and equipment purchases was $143.7 million for the nine months ended September 30, 2025, an increase from $110.1 million in the prior year period.
- Stock Repurchases: The company completed a $20.0 million stock repurchase program in the first half of 2025. A new $20.0 million program was authorized in May 2025, but no shares were repurchased under this new program in Q3 2025.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary & Outlook:
Management highlighted strong operational performance, citing improvements in occupancy and skilled mix (the percentage of higher-acuity patients). The company continues to focus on acquiring underperforming operations and integrating them to improve clinical and financial results. No specific forward-looking financial guidance (e.g., full-year revenue or EPS targets) was provided in the text.
Regulatory Environment & Risks:
- Legislation: The "One Big Beautiful Bill" (OBBB) was enacted on July 4, 2025. It includes provisions affecting Medicaid financing, such as a moratorium on new provider taxes and changes to eligibility redeterminations, which could impact reimbursement rates and state budgets.
- Government Shutdown: A federal government shutdown occurred starting October 1, 2025. Management anticipates minimal impact as Medicare and Medicaid are mandatory programs, though administrative delays are possible.
- Staffing Rules: The CMS Minimum Staffing Standards Final Rule was effectively halted by the OBBB and subsequent interim final rules, removing the immediate risk of mandated staffing ratios.
- Legal Proceedings: The company agreed to settle California wage and hour class action claims for $12.0 million (pending court approval). A DOJ investigation regarding Medicare and Texas Medicaid claims (CID issued in 2024) remains ongoing.
Unusual Items:
- Gain on Investments: The company recorded a $2.4 million realized gain on the sale of non-core investments in Q3 2025.
- Self-Insurance: Total self-insurance liabilities increased to $234.5 million as of September 30, 2025, reflecting accrued claims for general liability, workers' compensation, and health benefits.
Investor Verification Checklist
- Acquisition Integration: Verify the financial performance and occupancy trends of the 34 facilities acquired in the first nine months of 2025 to ensure they are meeting turnaround expectations.
- Regulatory Impact of OBBB: Monitor state-level responses to the OBBB, particularly in California, Texas, and Arizona, to assess potential reductions in Medicaid reimbursement rates.
- Lease Obligations: Review the $2.0 billion in operating lease liabilities and the terms of the Master Leases with CareTrust, noting the risk of cross-defaults if individual facilities fail to meet compliance standards.
- Legal Reserves: Confirm the status of the $12.0 million California wage settlement and the potential financial impact of the ongoing DOJ investigation into Medicare/Medicaid billing practices.
- Debt Covenants: Verify continued compliance with the Credit Facility covenants, specifically the maximum consolidated total net debt to consolidated EBITDA ratio (3.75:1.00) and minimum interest/rent coverage ratio (1.50:1.00).